Compare Otis Worldwide Corp (OTIS) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Otis Worldwide Corp vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Otis Worldwide Corp trades at $66.12 (market cap $25.03B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Otis Worldwide Corp is far larger — about 11× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Otis Worldwide Corp pays a 2.68% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| OTIS | SLS | |
|---|---|---|
Market Cap | $25.03B | $2.28B |
Volume | 2,974,901 | 3,128,960 |
Sector | Industrials | Health |
52-Week High | $93.62 | $15.46 |
52-Week Low | $64.05 | $1.39 |
Typical Hold Time | 65 Days | — |
Enterprise Value | $33.06B | $2.15B |
Dividend Yield | 2.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Otis Worldwide trades at $66.11, down 0.51% on the day and near its 52-week low. The stock shows bearish technical signals with mixed analyst sentiment (46.7% buy, 46.7% hold). Recent earnings have missed expectations for three consecutive quarters, though the company maintains stable revenue around $14.4 billion and strong service-based cash flows. CEO succession plans for 2027 and margin pressures in China remain key focus areas.
The investment outlook balances Otis's market leadership in elevator services against near-term headwinds. Upside potential exists if service margins recover and China demand stabilizes, supported by a consensus price target of $87.00. However, risks include persistent cost pressures, weak equipment demand, and high debt levels with a debt-to-asset ratio of 75.54% in 2025.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
